This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Jan;157(1):122-123.

doi: 10.1016/j.jtcvs.2018.09.021. Epub 2018 Sep 29.

The dark side of fluoroquinolones

Ari A Mennander¹

Affiliations

Affiliation

¹ Division of Cardiothoracic Surgery, Tampere University Heart Hospital, Tampere, Finland; Tampere University, Tampere, Finland. Electronic address: ari.mennander@sydansairaala.fi.

PMID: 30482528
DOI: 10.1016/j.jtcvs.2018.09.021

Free article

Editorial

The dark side of fluoroquinolones

Ari A Mennander. J Thorac Cardiovasc Surg. 2019 Jan.

Free article

. 2019 Jan;157(1):122-123.

doi: 10.1016/j.jtcvs.2018.09.021. Epub 2018 Sep 29.

Author

Ari A Mennander¹

Affiliation

¹ Division of Cardiothoracic Surgery, Tampere University Heart Hospital, Tampere, Finland; Tampere University, Tampere, Finland. Electronic address: ari.mennander@sydansairaala.fi.

PMID: 30482528
DOI: 10.1016/j.jtcvs.2018.09.021

No abstract available

PubMed Disclaimer

Comment on

Induction of human aortic myofibroblast-mediated extracellular matrix dysregulation: A potential mechanism of fluoroquinolone-associated aortopathy.
Guzzardi DG, Teng G, Kang S, Geeraert PJ, Pattar SS, Svystonyuk DA, Belke DD, Fedak PWM. Guzzardi DG, et al. J Thorac Cardiovasc Surg. 2019 Jan;157(1):109-119.e2. doi: 10.1016/j.jtcvs.2018.08.079. Epub 2018 Sep 21. J Thorac Cardiovasc Surg. 2019. PMID: 30528439

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources